Latest News and Press Releases
Want to stay updated on the latest news?
-
CINCINNATI, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Orange Grove Bio, a drug investment and development firm, today announced that it has established a new strategic collaboration with Bina, the...
-
Orange Grove Bio subsidiary, Preservation Bio, awarded $2.05 Million SBIR phase II grant to advance development of novel platelet preservation technology
-
CINCINNATI, March 23, 2023 (GLOBE NEWSWIRE) -- Orange Grove Bio, a drug investment and development firm, today announced that it has established new strategic collaborations with the Yonsei...
-
CINCINNATI, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Orange Grove Bio, a drug investment and development firm, today announced the establishment of a strategic collaboration with the Magnuson Center for...
-
John C. Byrd, M.D., Renowned Cancer Clinician and Researcher, Named Chair of Scientific Advisory Board New Collaboration with Northeast Ohio Medical University Further Demonstrates Company’s...
-
CINCINNATI, March 09, 2022 (GLOBE NEWSWIRE) -- Orange Grove Bio, a preclinical drug investment and development firm, and Cincinnati Children’s Hospital Medical Center today announced the...
-
Collaboration will Focus on Identifying Most Promising Research Emerging from Biotech Companies in Korea and U.S. for Licensing, Investment and Company Creation Partnership Supports Orange Grove’s...
-
CINCINNATI, Ohio and AURORA, Colo., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Orange Grove Bio, a preclinical drug investment and development firm, and the University of Colorado Anschutz Medical Campus (CU...
-
NEW YORK and PITTSBURGH, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Orange Grove Bio, a preclinical drug investment and development firm, and the University of Pittsburgh today announced the establishment of...
-
Mentorship Program Designed to Support Researchers and Clinical Scientists in Streamlining Translation of Novel Discoveries into New Therapeutic Candidates Pitch Contest to Award Winners Funding to...